Home > Boards > US Listed > Medical - Drugs > aTyr Pharma, Inc. (LIFE)

fascinating constellation w/ cash on hand @ > $2/sh

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
finesand Member Profile
 
Followed By 30
Posts 2,841
Boards Moderated 0
Alias Born 03/17/17
160x600 placeholder
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/29/2020 6:06:12 AM
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing GlobeNewswire Inc. - 9/21/2020 8:35:10 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 9/18/2020 4:27:24 PM
aTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Doses First Subjects in Phase 1 Trial of ATYR1923 in Japan GlobeNewswire Inc. - 9/15/2020 7:00:10 AM
Virtual Conference for Life Sciences Companies Broadcast Live September 17th, 2020 GlobeNewswire Inc. - 9/14/2020 8:35:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/14/2020 8:06:10 AM
aTyr Pharma Announces $20 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC GlobeNewswire Inc. - 9/14/2020 8:03:10 AM
aTyr Pharma to Present at September Investor Conferences GlobeNewswire Inc. - 9/9/2020 7:00:10 AM
aTyr Pharma to Present at Life Sciences Investor Forum on September 17th GlobeNewswire Inc. - 9/2/2020 7:00:10 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 8/18/2020 6:08:05 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2020 4:41:45 PM
aTyr Pharma Announces Second Quarter 2020 Results and Provides Corporate Update on ATYR1923 Clinical Trial Programs GlobeNewswire Inc. - 8/13/2020 4:00:10 PM
aTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Proceeds to Phase 1 Trial of ATYR1923 in Japan GlobeNewswire Inc. - 8/11/2020 7:00:10 AM
aTyr Pharma to Webcast Conference Call Reporting Second Quarter 2020 Financial Results GlobeNewswire Inc. - 8/6/2020 8:01:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/23/2020 4:28:33 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/22/2020 9:01:33 AM
aTyr Pharma Presents Preclinical Research Showing NRP2 Antibody Effects in Triple-Negative Breast Cancer at the 2020 AACR Vir... GlobeNewswire Inc. - 6/22/2020 8:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/20/2020 4:19:59 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/20/2020 4:18:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/18/2020 4:02:08 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/12/2020 5:07:45 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/12/2020 5:01:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/8/2020 5:15:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/8/2020 5:10:13 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/8/2020 5:05:21 PM
finesand   Tuesday, 06/26/18 01:10:54 PM
Re: z_deville post# 130
Post # of 184 
fascinating constellation w/ cash on hand @ > $2/sh
and an early pipeline worth even more.

We saw this last days and now the safety is in.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences